🇺🇸#BMY #отчетность
Bristol-Myers
Q2 EPS $1.09, consensus $1.10
sees yr adj. EPS $7.35 to $7.65, saw $7.95 to $8.25
Bristol-Myers
Q2 EPS $1.09, consensus $1.10
sees yr adj. EPS $7.35 to $7.65, saw $7.95 to $8.25
🇺🇸#BMY #отчетность
Bristol Myers
Q3 rev. $10.97B, est. $10.94B;
Adj EPS $2 vs $1.99 YoY;
Sees FY Adj EPS $7.5 to $7.65
Bristol Myers
Q3 rev. $10.97B, est. $10.94B;
Adj EPS $2 vs $1.99 YoY;
Sees FY Adj EPS $7.5 to $7.65